DHT: Explanation for the change of over 10% in operating result in QIV.2012 compared to QIV.2011

         According to the Financial Statement Quarter IV/2012, profit after tax of Quarter IV/2012 was VND 5,944,489,583 with an increase of 24.5% year on year.  Ha Tay Pharmaceutical JSC explained the increase in operating result in Quarter IV/2011 as follows:

-        Reason for the increase is that selling and financial expenses decreased.

HNX

>   OCH: Financial Statement Quarter 4/2012 (26/02/2013)

>   OCH: Financial Statement Quarter 4/2012 (holding company) (26/02/2013)

>   PPG: Financial Statement Quarter 4/2012 (26/02/2013)

>   PRC: Financial Statement FY 2012 (26/02/2013)

>   PTS: Financial Statement Quarter 4/2012 (26/02/2013)

>   VCM: Notice of record date for Annual General Meeting of Shareholders (26/02/2013)

>   HAG: Explanation for business results in Quarter 4/2012 (Consolidated FS) (26/02/2013)

>   PAC: Explanation for business result in Q4/2012 (26/02/2013)

>   TCL: Explanation for consolidated business results in quarter 4/2012 (26/02/2013)

>   KDC: Explanation for Q4.2012 business results (26/02/2013)